Zydus, Sunshine Healthcare JV to set up $20 million pharma manufacturing facility in Sri Lanka
Zydus Lifesciences and Sunshine Healthcare Lanka have formed a joint venture to establish a $20 million pharmaceutical manufacturing facility in Sri Lanka. The facility will strengthen local production, contribute to a reduction in import dependence, and improve access to high-quality medicines in the country. The joint venture aims to support technology transfer, build local manufacturing capability, and create employment opportunities in Sri Lanka.
- ▪The joint venture company, Zydus Sunshine Lifesciences, will manufacture pharmaceutical products for Sri Lanka's retail market.
- ▪The facility is being set up at the Board of Investment zone in Horana, Sri Lanka, and will be built on nearly four acres of land.
- ▪The partnership combines Zydus' global expertise in pharmaceutical manufacturing with Sunshine's strong local market presence and healthcare distribution capabilities.
Opening excerpt (first ~120 words) tap to expand
Zydus Lifesciences and Sunshine Healthcare Lanka have formed a joint venture to establish a $20 million pharmaceutical manufacturing facility in Sri Lanka.Foundation stone of the nearly four acres facility of Zydus Sunshine Lifesciences, the joint venture company, at the Board of Investment zone in Horana was laid on Friday (June 26, 2026).U.S. FDA issues warning letter to Zydus Lifesciences’ Baddi formulation unitComing against the backdrop of Sri Lanka prioritising domestic production in essential sectors, the plant will strengthen local production, contribute to a reduction in import dependence and improve access to high-quality medicines.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu.
Discussion
0 commentsMore from The Hindu
